- Home
- MRUS vs SR Comparison
MRUS vs SR Comparison
Compare MRUS & SR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRUS
- SR
- Stock Information
- Founded
- MRUS 2003
- SR 1857
- Country
- MRUS Netherlands
- SR United States
- Employees
- MRUS N/A
- SR N/A
- Industry
- MRUS Biotechnology: Pharmaceutical Preparations
- SR Oil/Gas Transmission
- Sector
- MRUS Health Care
- SR Utilities
- Exchange
- MRUS Nasdaq
- SR Nasdaq
- Market Cap
- MRUS 3.6B
- SR 3.6B
- IPO Year
- MRUS 2016
- SR N/A
- Fundamental
- Price
- MRUS $46.58
- SR $67.06
- Analyst Decision
- MRUS Strong Buy
- SR Hold
- Analyst Count
- MRUS 10
- SR 8
- Target Price
- MRUS $86.70
- SR $66.19
- AVG Volume (30 Days)
- MRUS 376.4K
- SR 380.1K
- Earning Date
- MRUS 10-31-2024
- SR 11-20-2024
- Dividend Yield
- MRUS N/A
- SR 4.51%
- EPS Growth
- MRUS N/A
- SR N/A
- EPS
- MRUS N/A
- SR 4.20
- Revenue
- MRUS $35,932,000.00
- SR $2,609,600,000.00
- Revenue This Year
- MRUS N/A
- SR $5.65
- Revenue Next Year
- MRUS $52.49
- SR $0.28
- P/E Ratio
- MRUS N/A
- SR $15.97
- Revenue Growth
- MRUS N/A
- SR N/A
- 52 Week Low
- MRUS $22.26
- SR $56.36
- 52 Week High
- MRUS $61.61
- SR $68.02
- Technical
- Relative Strength Index (RSI)
- MRUS 32.37
- SR 59.84
- Support Level
- MRUS $48.42
- SR $65.63
- Resistance Level
- MRUS $53.49
- SR $67.28
- Average True Range (ATR)
- MRUS 2.17
- SR 1.22
- MACD
- MRUS -0.54
- SR 0.34
- Stochastic Oscillator
- MRUS 5.73
- SR 95.93
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.
About SR Spire Inc.
Spire Inc is a public utility holding company with three reportable business segments: Gas Utility , Gas Marketing and Midstream. The Gas Utility segment includes the regulated operations of Laclede Gas, Alabama Gas Corporation (Alagasco), and EnergySouth Inc. The Utilities businesses operations include the purchase, retail, distribution, and sale of natural gas in Missouri, Alabama, and Mississippi. The Gas Utility segment generates a majority of the company's revenue but is subject to seasonal fluctuations. The Gas Marketing segment includes Laclede Energy Resources, Inc, whose operations include the marketing of natural gas and related activities on a non-regulated basis and the Midstream segment includes transportation and storage of natural gas.